Senate Majority Leader Mitch McConnell, R-Ky., had a problem when the American Health Care Act arrived from the House last month. What to do with a bill that is clogging your agenda but only 8 percent of Americans want you to pass and members of your own caucus swore was dead on arrival? McConnell couldn’t have missed the town halls filled with angry Americans who rely on Medicaid and see the Affordable Care Act’s protections for those with pre-existing conditions as a godsend. The House bill – which the Congressional Budget Office estimates would cause 23 million to lose coverage and end those protections for many – threatened all of that.
Faced with that reality, McConnell could have started over and had the Senate develop its own legislation, perhaps even working with Democrats on a bipartisan alternative that could withstand the test of time. Instead, McConnell put a plan in place to pass something close to the House bill using three simple tools: sabotage, speed and secrecy.
Taking advantage of those now well-documented efforts to sabotage the ACA, McConnell is reportedly telling his members they have no choice but to pass a replacement. By acting fast, McConnell hopes to minimize the continuing and mounting evidence of sabotage as insurers file rates in places such as North Carolina and Pennsylvania that explicitly break out the specific impact of Trump’s sabotage.
So last week McConnell deployed Rule XIV, a fast-track procedure that bypasses the committee process and moves the bill directly to the floor. Just as in the House, we’re on track to have a vote with no hearings (there were more than 100 for the ACA). Knowing the coverage loss will be significant, McConnell plans to vote within only days, or possibly even hours, of the release of the Congressional Budget Office score. Moving fast leaves opponents, and the public, with no time to catch up to the details.
The secrecy is also necessary for backroom deals. Given the opioid crisis in her state, one would think the AHCA’s severe Medicaid cuts would mean Shelley Moore Capito, R-W.Va., would never support it; the majority of opioid treatments in her state are provided by Medicaid. Similarly, one would think there is no price that would cause Lisa Murkowski, R-Alaska, to sign on to a deal whose consequences for her state would be worse than any other state. But McConnell is counting on being able to buy their votes relatively cheaply: possibly with a small “opioid fund” and an extra few years before the Medicaid expansion ends in certain states.
Of course there’s a better way. Not long ago, Sens. Bill Cassidy, R-La., Susan Collins, R-Maine, and Capito talked about finding solutions that would lead to more people covered, not fewer. That’s an approach that could bring many Democrats to the table. Given the Senate’s narrow margins, by voting no, the three of them or others have the power to change the course we’re on and put health-care reform on a path to long-term political stability. And McConnell himself might not even mind. Something short of 50 votes will preserve the Senate’s role as our deliberative body with the good judgment not to bow to the political winds, particularly when the country needs its checks and balances to work like never before.
Slavitt was acting administrator of the Centers for Medicare and Medicaid Services from 2015 to 2017.
The Washington Post